Blood test could replace risky biopsies for lung cancer patients
NCT ID NCT02372448
Summary
This study tested a blood test designed to detect specific genetic changes in lung cancer cells. The goal was to see if this 'liquid biopsy' could reliably match patients to targeted therapies, avoiding the need for invasive tissue biopsies. Researchers enrolled 206 patients with advanced lung cancer to validate this approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nice
Nice, France
-
Centre Antoine Lacassagne
Nice, 06100, France
-
Centre François Baclesse
Caen, 14000, France
-
Grenoble university hospital
Grenoble, 38043, France
-
Hôpital Tenon
Paris, 75020, France
-
Institut Gustave Roussy
Villejuif, 94800, France
-
Institut arnault tzanck
Saint-Laurent-du-Var, 06700, France
-
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, 54500, France
-
Marseille University Hospital
Marseille, 13915, France
-
Nancy university hospital
Nancy, 54511, France
-
Toulouse University Hospital
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.